Investor Relations
TOP IR CONTENTS
The Latest Presentation Materials
Past Presentation MaterialsSustainability Meeting
- Connection with Society - Chugai’s Value Creation
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
- Connection Within and Beyond the Company - Establishing a Pharmaceutical Technology Platform for Mid-Size Molecule Drugs
Dr. Kenji Maeda,
Head of API Process Development Dept., Pharmaceutical Technology Div.
- Connection with Capital Markets - Governance Enhancement and Future Challenges
Hideo Teramoto,
Independent Outside Director
Upcoming Events(Upcoming Events (2 Most Recent))
Events & PresentationsAnnual Report 2024(Integrated Report)
Past Annual Report
What's New
-
Roche’s Announcement Regarding Giredestrant (Presentation of Latest Data in Estrogen Receptor Positive Breast Cancer at SABCS)
-
Chugai Opens U.S. Partnering Office in South San Francisco to Accelerate Global Open Innovation
-
Donation to the University of Osaka Foundation for the Future “Shimon Sakaguchi Research Support Fund”
-
48-Week Phase III Results Presented at Japanese Retina and Vitreous Society Meeting Show that Vabysmo Sustained Vision Improvements in Japanese Patients with Angioid Streaks
-
Renalys Pharma’s Announcement Regarding Sparsentan (Results of Domestic Phase III Study for IgA Nephropathy)
External Evaluations
External Evaluations-
ESG Indices of Global Equities
DJSI is a leading ESG index developed by S&P Dow Jones Indices (USA). Companies are selected as a constituent annually based on an assessment of their economic, environmental and social sustainability.
-
ESG Indices Selected by GPIF
Chugai has been continuously included as a constituent stock of the all six ESG indices for Japanese equities since the initiation of ESG investment by the Government Pension Investment Fund (GPIF).
-
IR Activities
Chugai was ranked first for the first time in 2024 in the pharmaceutical sector for the “Selection of Excellent Companies in Corporate Disclosure by Securities Analysts” conducted by the Securities Analysts Association of Japan (SAAJ), a public interest incorporated association.
About Chugai
-
Company Outline
Company Profile, Business Process, Directors & Officers, Organization.
-
History of Chugai Pharmaceutical
Understanding Chugai’s history that fostered the business philosophy “Innovation all for the patients”
-
R&D
Easy-to-understand introduction of Chugai’s R&D structure, strategies and technologies.
